Author

Lingge Yu

Boston UniversityPrimary ORCID profile (0009-0000-3474-0048 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Lingge YuiD1 paper · Carnegie Mellon University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Organism:human· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Avrum E. SpiraiD· 1 shared Daniel P. StefankoiD· 1 shared Emily J. GreeniD· 1 shared Eric BurksiD· 1 shared Erika F. RodrigueziD· 1 shared Erin Kane· 1 shared Gang LiuiD· 1 shared Gregory A. FishbeiniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Avrum E. SpiraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Archetype analysis of lung adenocarcinoma premalignancy links heterogeneity in premalignant lesions to diverging features of invasive disease

Kelley E. Anderson, Linh My Tran, Kostyantyn Krysan, Yohana Kefella, Lingge Yu, Gregory A. Fishbein, Erika F. Rodriguez, Maryam Shabihkhani, Daniel P. Stefanko, Emily J. Green, Gang Liu, Hanqiao Liu, Sherry Zhang, Erin Kane, Mitra Mehrad, , Jennifer Beane

This study identifies four molecular archetypes of lung adenocarcinoma premalignant lesions using bulk RNA and exome sequencing, linking proliferation-associated features to aggressive tumor outcomes.

Molecular Cancer Research · May 6, 2026Peer-reviewedCancer Biology